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Aims Electronic (e)-cigarettes have been marketed as a ‘healthy’ alternative to traditional combustible cigarettes and as
an effective method of smoking cessation. There are, however, a paucity of data to support these claims. In fact,
e-cigarettes are implicated in endothelial dysfunction and oxidative stress in the vasculature and the lungs. The
mechanisms underlying these side effects remain unclear. Here, we investigated the effects of e-cigarette vapour on
vascular function in smokers and experimental animals to determine the underlying mechanisms.
...................................................................................................................................................................................................
Methods
and results
Acute e-cigarette smoking produced a marked impairment of endothelial function in chronic smokers determined
by flow-mediated dilation. In mice, e-cigarette vapour without nicotine had more detrimental effects on endothelial
function, markers of oxidative stress, inflammation, and lipid peroxidation than vapour containing nicotine. These
effects of e-cigarette vapour were largely absent in mice lacking phagocytic NADPH oxidase (NOX-2) or upon
treatment with the endothelin receptor blocker macitentan or the FOXO3 activator bepridil. We also established
that the e-cigarette product acrolein, a reactive aldehyde, recapitulated many of the NOX-2-dependent effects of
e-cigarette vapour using in vitro blood vessel incubation.
...................................................................................................................................................................................................
Conclusions E-cigarette vapour exposure increases vascular, cerebral, and pulmonary oxidative stress via a NOX-2-dependent
mechanism. Our study identifies the toxic aldehyde acrolein as a key mediator of the observed adverse vascular
consequences. Thus, e-cigarettes have the potential to induce marked adverse cardiovascular, pulmonary, and cere-
brovascular consequences. Since e-cigarette use is increasing, particularly amongst youth, our data suggest that ag-
gressive steps are warranted to limit their health risks.
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Introduction
According to the results of the Global Burden of Disease (GBD)
Study, tobacco smoking ranked second of all risk factors for global
deaths, just after high blood pressure.1 Electronic (e)-cigarettes have
been marketed as a ‘healthy’ alternative to traditional cigarettes, and
they are reported as an effective method of smoking cessation.2 As a
consequence, there has been a rapid growth of e-cigarette use, par-
ticularly in young people, such that by 2014 e-cigarettes were the
most commonly used tobacco product in the USA.3 The US Center
for Disease Control and Prevention (CDC) reports that among high
school students the e-cigarette use markedly increased from 1.5% to
20.8% (3.05 million students) between 2011 and 2018. This rapid
raise in e-cigarettes has raised concern about adverse health impacts
to middle and high school students.4 This concern is compounded by
the recent release of high nicotine content vaping devices without
complete understanding of the health consequences.5 Significant con-
cern comes also from very recent reports by the CDC, Food & Drug
Agency (FDA), and State Health Departments on ongoing investiga-
tions on severe pulmonary disease and deaths among people using e-
cigarettes6 and a preliminary report of a coordinated public health
investigation.7
There is considerable lack of clarity as to the overall population
health consequences of e-cigarette use. A majority of available studies
provide evidence that e-cigarette vaping is somewhat less detrimental
than tobacco cigarette smoking;8,9 however, the number of studies
and the amount of mechanistic insight are limited. If one considers
that e-cigarette vaping is associated with a decrease in the average
age of first-time (e)-cigarette users, the ‘healthier’ e-cigarette profile
might easily be abrogated (or even reversed) by the higher portion of
adolescent users. Thus, it is possible e-cigarette vaping could adverse-
ly impact overall population disability-adjusted life years thereby
bestowing a higher disease burden.
A deeper understanding of the health consequences of e-ciga-
rettes is warranted. There are several reports describing that e-cigar-
ette vaping can stimulate vascular and cardiac dysfunction, or prompt
oxidative stress and inflammation in the vasculature.8,10 Similarly,
vaping has been linked to increased blood pressure and enhanced
thrombogenesis.10–13 Collectively, these consequences of vaping
would be expected to initiate and/or exacerbate the process of ath-
erosclerosis.9,14 Thus, to garner further insight into the cardiovascu-
lar consequences of e-cigarette vaping, we conducted a study in mice
using unflavoured e-cigarette liquids with and without nicotine to de-
termine the impact on vascular (endothelial) function. In addition, we
characterized the mechanisms regarding oxidative stress and inflam-
mation, and validated our findings in human endothelial cells and in
healthy smokers.15
Materials and methods
E-cigarette exposure of human healthy
subjects and measurement of flow-mediated
dilation
All human data were collected in accordance with the declaration of
Helsinki and ethical approval was granted by the Landesärztekammer
Rheinland-Pfalz (Mainz, Germany; permit number: 837.412.14(9651)).
Written consent was received from all included individuals. Participants
were exposed to nicotine containing vapour from a commercially avail-
able e-cigarette device (Joyetech e-Go C). Endothelial function was
assessed in smokers by measuring flow-mediated dilation (FMD) and low
flow-mediated constriction (FMC) of the brachial artery prior to and
15 min after the e-cigarette vaping using our established methods.15
Arterial tonometry was used to measure shear rate and skin perfusion as
well as arterial stiffness was measured by pulse transit time (PTT) and
pulse wave velocity (PWV). Measurements were performed in smokers
since compliance of non-smokers (e.g. inhalation frequency and depth)
was very low based on a pilot study in n = 3 non-smokers vs. smokers.
For detailed protocol, characteristics of the included subjects and
inclusion/exclusion criteria see Supplementary material online (Supple-
mentary material online, Table S1).
E-cigarette exposure of mice
All animals were treated in accordance with the Guide for the Care and
Use of Laboratory Animals as adopted by the US National Institutes of
Translational perspective
With the present studies, we demonstrate that acute e-cigarette smoking produced a marked impairment endothelial function in chronic
smokers determined by flow-mediated dilation. Translational experiments in mice revealed that e-cigarette vapour causes oxidative stress in
the brain, the lung and in vessels, induces inflammation, and lipid peroxidation These adverse health effects were largely absent in mice lacking
phagocytic NADPH oxidase (NOX-2). The e-cigarette product acrolein, a reactive aldehyde, recapitulated many of the NOX-2-dependent
effects of e-cigarette vapour using in vitro blood vessel incubation. These results indicate that e-cigarettes use has the potential to induce
marked adverse cardiovascular, pulmonary, and cerebrovascular consequences. Since e-cigarette use is increasing, particularly amongst youth,
our data suggest aggressive steps are warranted to limit the cardiovascular and cerebrovascular health risks of e-cigarettes.
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Health and approval was granted by the Ethical Committee of the
University Medical Center Mainz and the Landesuntersuchungsamt
Rheinland-Pfalz (Koblenz, Germany; permit number: 23 177-07/G 16-1-
055 and extension E2). We used a total number of 124 C57BL/6 (male,
age 12± 3 weeks) and 27 Nox2 null mice (C57BL/6 background; male,
age 13± 3 weeks). The e-cigarette exposure system (inExpose, emka
Technologies, France) was equipped with an e-cigarette module
(Supplementary material online, Figure S1). Mice were exposed to e-cigar-
ette vapour over 1, 3, or 5 days for 2 h/day (6 times 20 min). E-cigarette li-
quid used for exposures (GermanFlavours, Germany) consisted of 50%
propylene glycol, 50% vegetable glycerol, and contained no additional fla-
vouring. For detailed protocol, see Supplementary material online.
The protocols for all other determined parameters and treatments
are described in the Supplementary material online.
Results
E-cigarette smoking causes endothelial
dysfunction in smokers
In otherwise healthy smokers (n = 20), e-cigarette vapour exposure
reduced FMD, increased FMC (by clear trend), decreased PTT, and
increased PWV (Figure 1A–C), clearly indicating profound induction
of endothelial dysfunction, arterial stiffness, impaired shear rate
[561.2 ± 267.7 vs. 647.0 ± 264.6 (mean ± SD); P = 0.016] and skin
perfusion (75.67 ± 47.73 vs. 41.90± 50.31; P = 0.009) by e-cigarette
vaping. Smoking habits were characterized by an actual daily tobacco
cigarette consume of 14 ± 5.03 and long-term use of 11.6± 8.0 pack-
years. Sixty-five percent of the volunteers had at least 1 and 15% >4
Figure 1 Effects of short-term e-cigarette vapour exposure on vascular function and oxidative stress in wild-type mice—validation of human vas-
cular function data. Endothelial function in healthy subjects was measured by FMD (A), FMC (B), and arterial stiffness by PTT/PWV (C) after single use
of e-cigarette in a cross-over fashion. Data are mean ± SD from n = 20 healthy subjects. (D) E-cigarette vaping for 6 h/day for 1, 3, and 5 days led to a
significant impairment of the endothelial function in wild-type mice. (E) E-cigarette vaping increased aortic reactive oxygen species (ROS) formation
as assessed by DHE staining, which was inhibited by NOX-2 inhibition by GSK2795039 (compound of GlaxoSmithKline). Representative microscopy
images are shown besides the densitometric quantification. (F) E-cigarette vaping significantly decreased endothelial •NO synthase (type 3) (eNOS)
and DHFR protein expression and (G) increased HO-1 protein expression. Representative blots are shown in Supplementary material online, Figure
S3D, all normalized to a-actinin. Data are presented as box (first and third quartiles, line = median) and whiskers (min, max) with jitter plot of single
values from n = 20 healthy subjects (A–C) or n = 6–18 (E) animals/group or 3–7 (F), 3–7 (G), or mean ± SD from n = 8–38 (D) samples/group (pooled
from 2–3 mice/sample). P-values as indicated except for (D) with *, P < 0.05 vs. unexposed controls.
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attempts in the past to quit smoking. More parameters (e.g. increased
heart frequency and sympathovagal balance) and subject characteris-
tics are summarized in Supplementary material online, Figure S2 and
Table S1.
Effects of e-cigarette vapour exposure on
vascular function and oxidative stress
E-cigarette vapour exposure (with nicotine) for 1, 3, and 5 days
caused endothelial dysfunction determined by acetylcholine-
dependent relaxation in wild-type mice upon all exposure protocols
(Figure 1D). Based on these initial findings on the time-dependent
effects, we decided to use the 3-day exposure protocol for compari-
son of liquids without and with nicotine as well as for other measure-
ments. Exposure to e-cigarette vapour without nicotine for 3 days
induced the most pronounced impairment of endothelial function,
followed by exposure to e-cigarette vapour with nicotine for 3 days
(Figure 1D). The 3-day exposure to e-cigarette vapour without nico-
tine also caused supersensitivity to norepinephrine-dependent vaso-
constriction (Supplementary material online, Figure S3A).
Endothelium-independent vasodilation (nitroglycerin-dependent re-
laxation) was not impaired by e-cigarette vapour (Supplementary ma-
terial online, Figure S3B). Endothelial dysfunction was coincident with
increased aortic oxidative stress determined as dihydroethidium
(DHE) fluorescence, with the most pronounced signal in the 3-day
exposure group without nicotine, which could be blocked by the
NOX-2 inhibitor GSK2795039 (Figure 1E) and was accompanied by
increased immune cell marker CD68 in the aorta (Supplementary
material online, Figure S3C). We also observed increased aortic and
cardiac 4-hydroxynonenal (4-HNE) immunostaining, despite no sig-
nificant down-regulation of its detoxifying enzyme, mitochondrial al-
dehyde dehydrogenase (ALDH-2) (Supplementary material online,
Figure S4). eNOS and dihydrofolate reductase (DHFR) protein ex-
pression was significantly decreased (Figure 1F). Aortic oxidative
stress condition was also reflected by up-regulated stress response
protein heme oxygenase-1 (HO-1) in the mice exposed for 3 days
(Figure 1G).
NOX-2 (gp91phox) is responsible for
e-cigarette vaping-induced vascular
damage
Oxidative burst was augmented in e-cigarette vapour-exposed wild-
type mice but not in Nox2/ mice (Figure 2A). In addition, ROS for-
mation in unexposed Nox2/mice was significantly lower compared
to unexposed wild-type mice (Figure 2A). Nox2/ mice had pre-
served endothelial function upon 3 days e-cigarette vapour (without
nicotine) exposure (Figure 2B), whereas wild-type mice exhibited
profound endothelial dysfunction (Figure 2B, dashed lines). Likewise,
Nox2/ mice were protected from the increased blood pressure
observed in wild-type mice (Figure 2C). We observed increased aortic
expression of eNOS and no change in DHFR or stress response pro-
tein HO-1 upon e-cigarette vapour-exposure in Nox2/ mice
(Figure 2D, E). HO-1 activity and plasma bilirubin levels were
increased in exposed wild-type but not Nox2/ mice (Figure 2F).
The lack of Nox2 also prevented any increase in aortic ROS/super-
oxide formation upon e-cigarette vapour exposure as measured by
three different methods (Figure 2G–I), which was also confirmed for
cardiac mitochondrial superoxide formation (Supplementary mater-
ial online, Figure S5A). NOX-2 induced oxidative stress also contrib-
utes to apoptotic cell death in e-cigarette vapour exposed wild-type
mice as revealed by cell death detection assay, whereas staining was
absent in Nox2/mice (Supplementary material online, Figure S5B).
Effects of e-cigarette vaping on vascular/
pulmonary phenotypic changes revealed
by immunohistochemistry and
immunoblot analysis
Immunohistochemical analysis revealed that e-cigarette smoking for
3 days increased significantly the staining for the oxidative stress
marker, 3-nitrotyrosine (3-NT), and the vasoconstrictor peptide, ET-
1 (Figure 3A). Similarly, e-cigarette smoking increased the inflamma-
tion marker, inducible nitric oxide synthase (NOS-2, iNOS), and the
ROS-producing enzyme NOX-2 (Figure 3B). In lung sections and
homogenate, the immunostaining for the ROS producing enzyme
NOX-2 was augmented in the 3-day exposure groups
(Supplementary material online, Figure S6). Overall, Nox2/ mice
exhibited reduced e-cigarette vapour-induced lung staining for oxida-
tive stress (3-NT and 4-HNE) and inflammation (interleukin-6 and
CD68) compared to wild-type mice (Supplementary material online,
Figure S7). Collectively, these data indicate that e-cigarette vapour
induces a NOX-2-dependent pro-oxidative and inflammatory state
in the lungs and vasculature.
Effects of e-cigarette vaping on cerebral
oxidative stress and antioxidant defence
Exposure to e-cigarette vapour for 3 days without nicotine increased
ROS formation (DHE cryo staining) in the frontal cortex of the brain,
an effect that was severely blunted by pharmacological inhibition with
the NOX-2 inhibitor GSK2795039 (Figure 4A). Likewise, the specific
neuronal •NO synthase (type 1) (nNOS) inhibitor ARL-17477 and
Nox2 deficiency suppressed the DHE signal identifying uncoupled
nNOS and NOX-2 as the sources of oxidative stress in brain of
exposed mice (Figure 4B). The fluorescence staining results were also
mirrored by specific superoxide quantification using an HPLC-de-
pendent method (Figure 4D). Exposure to e-cigarette vapour for 3
days without nicotine caused a down-regulation of nNOS in whole
brain homogenate at the mRNA and protein levels (Figure 4C, E),
which was prevented by genetic Nox2 deletion (Figure 4F). We found
that cerebral Forkhead box protein 3 (Foxo3) mRNA, an antioxidant
transcription factor, was significantly down-regulated in brain tissue
of mice in the 3-day exposure groups, whereas Nox1 was up-
regulated at the mRNA level (Figure 4E). These effects were not
observed in Nox2/ mice (Figure 4F). Thus, e-cigarette vapour also
induces a NOX-2-dependent pro-oxidative and inflammatory milieu
in the cerebral circulation.
Effects of e-cigarette vapour condensate
vs. e-cigarette liquid on viability of
cultured human endothelial cells and
phenotypic changes
Treatment of cultured human endothelial cells with e-cigarette va-
pour condensate caused a concentration- and time-dependent loss
E-cigarette, ROS, and vascular dysfunction 2475
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..of cellular viability (Supplementary material online, Figure S8A, B). The
e-cigarette liquid itself had a qualitatively similar impact on the cells as
the condensate at the highest concentration (Supplementary material
online, Figure S8A, C). However, lower concentrations of the conden-
sate exhibited greater toxicity than the liquid (compare
Supplementary material online, Figure S8B, C), suggesting that
vaporization creates additional toxicity. There was no significant ef-
fect of nicotine on cell viability, in either condensate or liquid. The
condensate also induced a more pronounced inflammatory pheno-
type (IL-6 levels) in the endothelial cells than the liquid after 72 h of
treatment (Supplementary material online, Figure S8D). The antioxi-
dant enzyme PEG-catalase and the NOX-2 inhibitors gp91 ds-tat or
Figure 2 Effects of short-term e-cigarette vapour exposure on vascular function and oxidative stress in Nox2/ (gp91phox/) vs. wild-type
mice. (A) E-cigarette vaping caused a stronger oxidative burst in whole blood of wild-type mice, whereas no significant change was observed in whole
blood of Nox2/mice. In addition, the overall stimulated signal was much lower in Nox2/mice. (B) E-cigarette vaping caused endothelial dysfunc-
tion in wild-type mice, which was prevented by Nox2/. (C) E-cigarette vaping increased systolic and diastolic blood pressure in wild-type but not in
Nox2/mice. (D, E) E-cigarette vaping paradoxically increased protein expression of eNOS while no changes were observed in the regulation of ex-
pression of DHFR and HO-1. Representative blots are shown below the densitometric quantification. (F) Bilirubin levels (product of HO-1 activity)
in plasma were increased in wild-type but not in Nox2/mice. Representative chromatograms are shown along with the quantification. Nox2 knock-
out prevented e-cigarette vaping-induced increase in aortic ROS/superoxide formation as assessed by lucigenin enhanced chemiluminescence (ECL)
(G), high performance liquid chromatography (HPLC)-based quantification of DHE oxidation products (H) and DHE staining (I). Representative chro-
matograms and microscopy images are shown along with the quantifications. Data are presented as box (first and third quartiles, line = median) and
whiskers (min, max) with jitter plot of single values from n = 5–10 (A), 6–22 (C), 4 (D, E) and at least 5 (F), 6–15 (G), 4 (H), or 4–18 (I) or mean ± SD
from 6–38 (B) animals/group. P-values as indicated except for (B) with *, P < 0.05 vs. unexposed controls.
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GSK2795039 increased cell viability after incubation with condensate
pointing to a significant role of NOX-2 dependent ROS formation in
causing cell death (Supplementary material online, Figure S9).
Although the used concentration of the condensate in the cell culture
medium is supra-physiological and clearly represents a model of cel-
lular toxicity in order to study adverse effects in a short-time scale,
these data suggest that e-cigarette vaporization adds additional tox-
icity to its components via NOX-2 induced oxidative stress, prompt-
ing us to investigate this process.
E-cigarette liquid and vapour condensate
contain toxic aldehydes exerting adverse
effects on cells and tissue ex vivo by
activation of NOX-2
Using HPLC analysis of 2,4-dinitrophenylhydrazine (DNPH)-
derivatization products, we found mM concentrations of formalde-
hyde, acetaldehyde, butyraldehyde, and acrolein in E-cigarette liquid
and to much larger extend in vapour condensate: 16 ± 2 formalde-
hyde, 0.19± 0.04 acetaldehyde, 1.6± 0.1 butyraldehyde and
0.49± 0.09 acrolein (Figure 5A, for representative chromatograms
see Supplementary material online, Figure S10). These values were in
the range of or slightly below previously reported values in other e-
cigarette studies.16,17 Moreover, we could confirm the presence of
formaldehyde, acetaldehyde, propionaldehyde, butyraldehyde, and
acrolein in the E-cigarette liquid by liquid chromatography/mass spec-
trometry (LC/MS) analysis and their signal intensities were at least 9-
fold higher in vapour condensate (Figure 5B and Supplementary
material online, Table S2). In addition, we observed a [M-H]-
C10H9N4O4 signal, providing evidence for the presence of DNPH
adducts of either crotonaldehyde and/or methacrolein, both toxic
aldehydes with known harmful effects on the cardiovascular sys-
tem.18–21
To estimate the toxicity of these vapour-enhanced products, we
incubated cultured human endothelial cells with mixtures of alde-
hydes at relevant concentrations. We found they produced
concentration-dependent cell death (Supplementary material online,
Figure S11A) and increased expression by trend of the inflammatory
marker COX-2 (Supplementary material online, Figure S11B). This
was accompanied by aldehyde-dependent NOX-2 activation as
measured by higher p47phox protein content in membranous frac-
tions of endothelial cell pellets as determined by ratio of membrane/
cytosol p47phox content (Figure 5C). Since acrolein can cause NOX-
2 activation,22 we tested lung tissue for acrolein protein-adducts and
found more pronounced staining in lungs of in e-cigarette vapour-
exposed mice (Figure 5D). Finally, we observed that vascular ROS for-
mation was significantly increased by acrolein in aorta of wild-type
but not Nox2/ mice and was blocked by GSK2795039 (Figure 5E).
Mixtures of aldehydes also caused phenotypic changes in cultured
RAW macrophages and increased expression by trend of p47phox,
p67phox, and COX-2 (Supplementary material online, Figure S12).
Although the used concentrations of the aldehydes in the cell culture
medium were based on those found in the e-cigarette condensate
and liquid, these experiments are supra-physiological and represent a
model of cellular toxicity in order to study adverse effects in a short-
time scale.
Figure 3 Effects of short-term e-cigarette vaping on vascular nitrotyrosine (3-NT), endothelin-1 (ET-1), inducible nitric oxide synthase, and
NADPH oxidase subunit (NOX-2) expression. (A) E-cigarette vaping increased vascular 3-NT and ET-1 as well as (B) iNOS and NOX-2 expression.
Representative microscopy images are shown below the densitometric quantification. Data are presented as box (first and third quartiles, line = me-
dian) and whiskers (min, max) with jitter plot of single values from n = 4–8 (A) and 5–8 (B) animals/group. P-values as indicated.
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Figure 4 Effects of short-term e-cigarette vaping on cerebral oxidative stress. (A) E-cigarette vaping increased cerebral ROS formation (assessed
by DHE) which was inhibited by the specific NOX-2 inhibitor GSK2795039. (B) Cerebral ROS formation (assessed by DHE) was also inhibited by
the specific nNOS inhibitor ARL-17477 and genetic Nox2 deletion. (C) nNOS in the frontal cortex tended to be decreased in response to E-cigarette
vaping. Representative blots are shown next to the densitometric quantification. (D) E-cigarette vaping increased cerebral superoxide formation
(assessed by HPLC-based quantification of DHE oxidation products) which was inhibited by genetic Nox2 deletion. Representative chromatograms
are shown along with the quantification. (E) E-cigarette vaping decreased mRNA expression of Foxo3 and nNOS and increased expression of Nox1
mRNA levels. (F) These genes were differentially or not significantly regulated in the frontal cortex of e-cigarette vapour-exposed Nox2/ mice.
Data are presented as box (first and third quartiles, line = median) and whiskers (min, max) with jitter plot of single values from n = 4 (GSK-group)
and at least 4 (Ctr and exposures) animals/group (A, B) and 4 samples/group (pooled from 3 mice/sample) (C), 6–8 (D), 9–12 (E), and 4–8 (F) animals/
group. P-values as indicated.
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Figure 5 E-cigarette liquid and vapour condensate contain toxic aldehydes as revealed by DNPH derivatization with HPLC and LC-MS analysis
exerting toxic effects on cultured endothelial cells. (A) Quantification of identified aldehydes by HPLC analysis and known DNPH-aldehyde standards.
Representative chromatograms are shown in Supplementary material online, Figure S10. (B) List of identified compounds (DNPH or aldehyde-
DNPH) adducts in e-cigarette vapour condensate by LC-MS analysis with a representative chromatogram. The relative abundance of the aldehyde-
DNPH adducts is provided in Supplementary material online, Table S2. (C) Protein expression of p67phox and p47phox was determined by western
blot analysis in membranous and cytosolic protein-fractions from pellets of EA.hy926 cells upon incubation with toxic aldehyde mixtures of formalde-
hyde (0.5–5 mM) and acetaldehyde/butyraldehyde/acrolein (each 0.05–0.5mM). The ratio of membraneous/cytosolic p67phox and p47phox reflects
NOX-2 activation state. Representative western blots are shown besides the densitometric quantification. (D) Protein adducts of acrolein were
determined by western and dot blot analysis in lung tissues of control or E-cigarette vapour-exposed mice. Representative original western and dot
blots are shown besides the densitometric quantifications. (E) Vascular ROS formation by acrolein was determined using dihydroethidium (DHE,
1mM)-dependent fluorescence microtopography in aortic cryo-sections. The contribution of NOX-2 to this ROS signal was assessed by comparison
of aortic sections of wild-type vs. Nox2 deficient mice and pharmacological inhibition by GSK2795039. Representative microscopy images are shown
below the densitometric quantification. Data are presented as box (first and third quartiles, line = median) and whiskers (min, max) with jitter plot of
single values from n = 4–5 (C, D) and 4–16 (E) or mean ± SD from n = 3 (A, B) experiments or animals per group. P-values as indicated.
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Figure 6 E-cigarette vaping induced cardiovascular complications are prevented by pharmacological ET-1 receptor blockade and FOXO-3 activa-
tion. ET-1 receptor blockade by macitentan and FOXO-3 activation by bepridil prevent e-cigarette vaping induced blood pressure increase (A), endo-
thelial dysfunction (B), aortic superoxide formation by lucigenin ECL (C), and aortic ROS formation by DHE staining (D). Representative microscopy
images are shown besides the densitometric quantification. Data are presented as box (first and third quartiles, line = median) and whiskers (min,
max) with jitter plot of single values from at least n = 8 (A), 7 (C), and 4 (D) or mean ± SD from at least n = 8 (B) animals per group. Significance as indi-
cated except for (B) with *, P < 0.05 vs. unexposed controls. (E) Central scheme: proposed mechanisms of E-cigarette mediated cerebro/cardiovas-
cular complications from studies in mice. The described adverse effects are also operative in the disease development and progression of classical
cerebro/cardiovascular disease such as stroke, atherosclerosis, hypertension, and coronary artery disease. Light blue colour items represent pharma-
cological/genetic interventions. NOX and Nox refers to protein and mRNA of NOX-2 isoform.
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Mechanistic insights into e-cigarette
vapour induced cardiovascular
complications in mice by
pharmacological interventions
In order to further elucidate the detrimental role of ET-1 and
FOXO-3 signalling, mice were exposed to e-cigarette vapour and
treated simultaneously with the ET-1 receptor blocker macitentan
and the FOXO-3 activator bepridil. Both therapies prevented blood
pressure increase, endothelial dysfunction and vascular ROS/super-
oxide formation (Figure 6A–D), suggesting a central role for ET-1 and
FOXO-3 in aggravating or preventing e-cigarette vapour induced car-
diovascular complications.
Discussion
With the present study, we found that a single episode of e-cigarette
smoking induced endothelial dysfunction even in chronic smokers.
To gain mechanistic insight, we examined the vascular and cerebral
consequences of short-term e-cigarette vapour exposure in mice
and found impaired endothelial NO signalling and endothelial dys-
function with e-cigarettes. We also determined that e-cigarette va-
pour exposure increased oxidative stress and inflammation in aorta,
lung, and brain. Moreover, this phenotype was dependent upon the
NADPH oxidase family member, NOX-2, as Nox2/ mice were re-
sistant to the consequences of e-cigarette vapour exposure. Since
we observed that vaporization enhanced the toxicity of e-cigarette li-
quid, we examined vaporization products. Using quantitative HPLC
and qualitative LC/MS analysis, we identified toxic aldehydes gener-
ated during vaporization and validated their deleterious effects in cul-
tured endothelial cells. One model aldehyde, acrolein, was observed
to recapitulate the impact of e-cigarette vapour in a NOX-2-
dependent manner. Thus, e-cigarette vapour exerts a broad injurious
influence on the vasculature due, in part, to vaporization-enhanced al-
dehyde generation that activates NOX-2 leading to oxidative stress,
inflammation, and endothelial dysfunction.
E-cigarette use in current smokers and
adolescents
The preponderance of data regarding e-cigarettes and smoking cessa-
tion clearly indicates these devices are not superior to approved
nicotine replacement therapy or usual care.23 Indeed, a recent
American College of Preventive Medicines Practice Statement
reported that there is limited evidence to support short-term exclu-
sive use of e-cigarettes in adults who quit smoking. Moreover, the re-
port indicates that among youth, there is no known benefit, but there
is significant concern for harm.23 Our data highlight this concern as
we observed significant consequences of e-cigarettes on the vascular
endothelium with just one episode of vaping. Our observations pro-
vide additional support for the FDA concern for an ‘epidemic’ surge
in e-cigarette use by adolescents that prompted regulatory action
against more than 1300 US retailers and five major manufacturers for
their roles in perpetuating youth access to e-cigarettes.5 Recent
warnings and reports by the FDA, CDC, and other public health
authorities on severe pulmonary disease and deaths among people
using e-cigarettes further support these concerns.6,7 Thus, the data
reported here suggest that adolescent e-cigarette use clearly should
not be considered as being safe from a vascular, cardiac, or pulmon-
ary point of view.
Cardiovascular side effects of e-cigarette
and tobacco smoking
We examined the effects of e-cigarette smoking on vascular function
using the FMD/FMC15 and fingertip tonometry approach. Acute e-
cigarette smoking caused a significant reduction in FMD in smokers,
FMC increase by trend, impaired skin perfusion, and increased arter-
ial stiffness parameters (PTT, PWV), indicating that e-cigarette va-
pour induces endothelial dysfunction with a reduction in vascular
nitric oxide bioavailability,15 most likely due to increased oxidative
stress. This observation bears a striking resemblance to the adverse
impact of chronic cigarette smoking that causes endothelial dysfunc-
tion that is improved by the acute administration of the antioxidant,
vitamin C.24 These observations are also in keeping with other data
comparing e-cigarette vapour and cigarette smoke. Both appear to
increase oxidative stress, to degrade blood–brain barrier integrity
and to induce vascular inflammation in endothelium.10 Likewise, both
tobacco smoke and e-cigarette vapour induce cerebrovascular in-
flammation and post-stroke ischaemia/reperfusion damage in mice
and these effects are attenuated by stimulating the NRF2 antioxidant
response.10 Chronic (8-month) mouse exposure to e-cigarette va-
pour and cigarette smoke (3R4F reference) revealed qualitatively
comparable adverse effects on cardiac function, arterial stiffness, and
endothelial function.14 Thus, abundant data in this report and by
other investigators indicate that e-cigarette vapour shares many of
the same adverse vascular consequences of authentic tobacco
smoke. This notion is also strongly supported by a recent large scale
cross-sectional study in more than 30 000 subjects indicating that
daily e-cigarette use, adjusted for smoking conventional cigarettes as
well as other risk factors, is associated with increased risk of myocar-
dial infarction.25
A human interventional study showed a significant increase in
serum oxidative stress markers (including soluble NOX2-derived
peptide), decrease in circulating nitric oxide products and vitamin E
levels, as well as impaired endothelial function upon e-cigarette va-
pour and tobacco cigarette smoke exposure.8 Likewise, regular e-cig-
arette users had higher cardiac sympathetic activity and serum
oxidative stress markers,13 healthy non-smokers showed increased
blood pressure and heart rate upon single use from an e-cigarette11
and smokers responded with increased blood pressure and pulse-
wave velocity.9 Although the majority of available studies provide evi-
dence that e-cigarette vaping is somewhat less detrimental than to-
bacco cigarette smoking, they are all in good accordance with our
present human vascular/hemodynamic findings as well as NOX-2
centred mechanism in exposed mice.
E-cigarettes stimulate superoxide
production via NOX-2 activation
In the study presented here, we established that e-cigarette vapour
exposure produced increased markers of oxidative stress in aortic
and brain tissue of mice. These observations of increased oxidative
stress with e-cigarette vapour may explain its impact on the endothe-
lium. Oxidative stress is known to produce endothelial dysfunction
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by increased oxidative breakdown of NO and peroxynitrite forma-
tion,26 as well as limiting the availability of tetrahydrobiopterin, an es-
sential eNOS cofactor.27 An important contribution of this work is
the identification of Nox-2 as a key mediator of e-cigarette vaping-
induced oxidative stress. We demonstrated that e-cigarette vapour
leads to up-regulation of NOX-2 activity and that mice lacking the
Nox2 gene do not demonstrate oxidative stress and endothelial dys-
function in response to e-cigarette vapour, similar to mice exposed
to the environmental risk factor aircraft noise that were also pro-
tected when Nox2 gene was deleted.28 This finding nicely mirrors
previous reports that patients with chronic granulomatous disease
(Nox2 hereditary deficiency) showed better FMD than healthy
controls.29
E-cigarette vaping is also known to stimulate inflammatory path-
ways,10 findings consistent with our observations of NOS-2 induction
and IL-6 release with e-cigarette vapour. Our data implicate NOX-2
as a key mediator of the inflammatory response as we observed atte-
nuated e-cigarette vapour-induced inflammation in the Nox2-null
mice compared with wild-type animals. These data linking NOX-2 to
the adverse consequences of e-cigarette vapour are consistent with a
recent study involving healthy subjects (smokers and non-smokers)
smoking one classical cigarette and nine puffs from an e-cigarette in a
cross-over design.8 That study also revealed that both traditional and
e-cigarettes produced comparable effects such as increases in a
serum oxidative stress marker (8-isoprostanes), NOX-2 activation,
and reduced endothelial function. Thus, e-cigarette vapour appears
to mediate many of its adverse vascular consequences through
NOX-2 activation, e.g. as shown here by nNOS uncoupling that was
absent in Nox2 deficient mice.
This was also nicely supported by increased ET-1 signalling sup-
porting the previously reported crosstalk between NOX-2 and ET-
1,30 where ET-1 induces expression of NOX-2 and formation of
ROS and vice versa NOX-2 derived ROS activate the promoter for
ET-1 expression with enhanced ET-1 dependent vasoconstriction,31
all of which was corrected by pharmacological ET-1 receptor block-
ade with macitentan. The compensatory, however futile compensa-
tory up-regulation of HO-1 was observed in our exposed mice
together with higher bilirubin plasma levels (NRF2-dependent oxida-
tive stress response), all of which was normalized in Nox2 deficient
mice. In contrast, the FOXO-3 dependent oxidative stress response
was inactivated by down-regulation of Foxo3 mRNA in exposed
mice, which was overcome by pharmacological FOXO-3 activation
by bepridil. Therefore, the here reported pathomechanisms of e-cig-
arette vapour exposure show striking similarities with the reported
molecular pathways of adverse cardio/cerebrovascular effects of ex-
posure of mice to aircraft noise.28,32
E-cigarettes and aldehyde toxicity
in vitro and in vivo
Another important contribution of this study is the identification of
reactive aldehydes as important mediators of e-cigarette vapour-
mediated endothelial dysfunction. The vaporization process creates
compounds with high cellular toxicity that we identified as reactive
aldehydes in the vapour condensate. Our data that mixtures of the
identified aldehydes in the vapour condensate induce endothelial cell
death and immune cell activation is consistent with a well-established
literature on the subject (see also Supplementary material online for
extended discussion).33–35 Of particular note in our data, we found
that one model aldehyde, acrolein, induced stimulation of superoxide
production in aortic tissue that was NOX-2-dependent as it was al-
most completely suppressed in vessels from animals lacking NOX-2.
These data provide a proof of concept for previous studies showing
that acrolein from cigarette smoke extract activates NOX-2 in cul-
tured endothelial cells.22 Previous studies also reported toxic effects
of acrolein on lung endothelial barrier function, which was associated
with oxidative stress and brisk inflammation, however with a more
pronounced toxicity in the presence of nicotine.36 Components of li-
quid or condensate were previously investigated in cultured human
lung cells and almost no adverse effects were observed in contrast to
detrimental effects by mainstream tobacco cigarette smoke.37 These
observations clearly link vaporization-induced aldehydes to the proc-
esses that mediate e-cigarette vapour-induced endothelial dysfunc-
tion and inflammation.
Limitations
The missed recruitment of healthy non-smokers subjects should be
recognized as limitation of the present study. Nevertheless, a repeat
demonstration of the substantial adverse side effects of e-cigarette
smoking on endothelial function of chronic smokers further substan-
tiates the concept that e-cigarettes are not at all a ‘healthy’ alternative
to traditional combustible cigarettes.
Conclusions and clinical
implications
With the present studies we demonstrate that acute e-cigarette va-
pour exposure causes endothelial dysfunction in chronic smokers,
induces inflammation and oxidative stress in vascular and cerebral tis-
sue, and increases blood pressure in experimental animals (central
scheme in Figure 6E). Importantly, we identified NOX-2 as an import-
ant source of e-cigarette-driven vascular oxidative stress and inflam-
mation with an important role of ET-1 (shown by macitentan
therapy) and FOXO-3 (shown by bepridil therapy) signalling in aggra-
vation or prevention of these adverse effects. Finally, we established
that aldehydes produced during vaporization were present in vivo and
sufficient to produce NOX-2-driven oxidative stress and inflamma-
tion. If one considers the ongoing epidemic of e-cigarette use among
adolescents, our data provide a strong warning that the perceived
‘safety’ of these products (compared to tobacco) is not warranted,
which is in good accordance with a recent systemic literature review
concluding that ‘e-cigarette should not be labelled as a safe cardiovas-
cular product’.38 We also like to state that the results of the present
studies have no e-cigarette industry related conflict of interest, an in-
formation that seems to be important since recent studies indicate
that e-cigarette industry funding is more likely to lead to results that
demonstrate that e-cigarettes are harmless.39 Our data suggest ag-
gressive steps should be taken to protect our children from health
risks caused by e-cigarettes, especially e-cigarettes should be men-
tioned like tobacco cigarettes as an important health risk factor in the
European40 and American Heart Association Guidelines for
prevention.41
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Supplementary material
Supplementary material is available at European Heart Journal online.
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